Morepen Laboratories Limited (MOREPENLAB)
NSEINR 44.61-0.49%
Price Chart
Key Statistics
Market Cap
INR 41.47B
P/E Ratio
29.92
Revenue (TTM)
INR 17.75B
Volume
3.16M
52W High
INR 100.90
52W Low
INR 40.20
Dividend Yield
0.00%
Beta
1.49
Technicals
50-Day MA
83.8556
200-Day MA
61.7416
52 Week High
100.9
52 Week Low
40.2
About MOREPENLAB
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationall.
Employees
2152
Headquarters
Gurugram, India
CEO
Mr. Sushil Suri B.Sc., F.C.A., FCA
Latest News
Morepen Lab targets ₹5,000-cr revenue by 2030 - BusinessLine
2024-12-11 • Google News
Morepen Lab rallies 8% in weak market; zooms 63% over QIP price in 1 month - Business Standard
2024-09-04 • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
N/A
N/A
Environmental Risk Score
N/A
N/A
Social Risk Score
N/A
N/A
Governance Risk Score
N/A
N/A
Controversy Level
ESG data provided by Sustainalytics, Inc.
MOREPENLAB
Category Average
N/ANone Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg